Immunome
IMNM
57 hedge funds and large institutions have $230M invested in Immunome in 2023 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 5 closing their positions.
1,071% more capital invested
Capital invested by funds: $19.7M → $230M (+$210M)
440% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 5
430% more call options, than puts
Call options by funds: $806K | Put options by funds: $152K
167% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 6
63% more funds holding
Funds holding: 35 → 57 (+22)
30.95% more ownership
Funds ownership: 19.37% → 50.32% (+31%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$32.5M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
+$32.3M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$32.3M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$11.6M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AGM
Alpine Global Management
New York
|
-$1.44M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$693K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$255K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$152K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$102K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MLA
51
MB, Levis & Associates
Center Valley,
Pennsylvania
| $25.4K | – | – | – |
|
52
Wells Fargo
San Francisco,
California
| $21.6K | +$1.41K | +170 | +9% |
|
|
PAS
53
Point72 Asia (Singapore)
Singapore
| $5.65K | +$4.39K | +528 | New |
|
|
NFSG
54
Newbridge Financial Services Group
Boca Raton,
Florida
| $2.41K | – | – | – |
|
|
FFA
55
Farther Finance Advisors
San Francisco,
California
| $1.07K | – | – | – |
|
56
Federated Hermes
Pittsburgh,
Pennsylvania
| $931 | +$723 | +87 | New |
|
|
EC
57
EntryPoint Capital
New York
| $268 | +$208 | +25 | New |
|
|
58
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$693K | -92,593 | Closed |
|
|
SSA
59
Schonfeld Strategic Advisors
New York
| – | -$152K | -18,201 | Closed |
|
|
WA
60
Wealth Architects
Mountain View,
California
| – | -$92.8K | -11,110 | Closed |
|
|
DWA
61
Dorsey Wright & Associates
Pasadena,
California
| – | -$25.9K | -3,100 | Closed |
|
62
UBS Group
Zurich,
Switzerland
| – | -$117 | -14 | Closed |
|
IMNM Hedge Fund Activity: Q4 2023 in Review
57 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Immunome (IMNM) for Q4 2023, worth a combined $230M — up 1,071% from $19.7M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new IMNM positions and 5 closed out — a net gain of 22 holders — while 16 added to existing stakes and 6 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $32.5M. The largest seller was Alpine Global Management, cutting an estimated $1.44M.
- 57 institutional investors held Immunome (IMNM) as of Q4 2023, up from 35 in Q3 2023.
- Funds reported $230M of Immunome stock for Q4 2023, up 1,071% quarter-over-quarter.
- 27 funds opened new Immunome positions in Q4 2023 and 5 closed out, a net change of +22 holders.
- The largest Immunome buyer in Q4 2023 was Fidelity Investments, an estimated $32.5M added.
- The largest Immunome seller in Q4 2023 was Alpine Global Management, an estimated $1.44M sold.
Based on aggregated 13F filings for Q4 2023.